🇨🇦 TOFOGLIFLOZIN CSG452 in Canada

TOFOGLIFLOZIN CSG452 (TOFOGLIFLOZIN CSG452) regulatory status in Canada.

Marketing authorisation

TOFOGLIFLOZIN CSG452 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TOFOGLIFLOZIN CSG452 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for TOFOGLIFLOZIN CSG452 in Canada?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.